“…While pathologic features consistent with IBCL are often detected in the bone marrow at the time of diagnosis of type II MC (3,5,(6)(7)(8)(9)(10)(11), the clinical manifestations, which are typical of a systemic autoimmune and chronic infectious disease and lack neoplastic features even at followup, provide evidence against a neoplastic disorder in the large majority of cases (3,6,12). An overtly neoplastic evolution is observed in a minority of patients with type II MC (Ͻ15%) (6,12), and other adverse events during followup usually affect the mortality and morbidity rates.…”